Nassim Morsli - Info zur Person mit Bilder, News & Links

	Ingelheim

	Scagliotti Cancer Ute von Wangenheim Zitiert Nintedanib Giorgio Patients Phase III Baverel José Barrueco Sanjay Popat

News

(1 - 4 von 5

–alle anzeigen

)

onkoserv - der aktuellste und unabhängige deutsche Informationsdienst...

www.onkoserv.de

Onkoserv ist der aktuellste deutsche Informationsdienst für die klinische Onkologie

History of Changes for Study: NCT

clinicaltrials.gov

Study Officials: Nassim Morsli, MD Study Director Merck KGaA, Darmstadt, Germany. Locations: Germany. Central Contact Darmstadt, Germany ...

MEDICAL TRIBUNE CZ > Klinická studie fáze III srovnávající u pacientů...

www.tribune.cz

Informační portál nakladatelství MEDICAL TRIBUNE CZ, s.r.o. určeny odborníkům pracujícím ve zdravotnictví. Najdete zde obsahy titulů, aktuality, dokumenty,...

NEWS letter No.4 - cliniporatorwww.cliniporator.com › goods › newsletters

www.cliniporator.com

première rangée, Nassim Morsli,. Caroline Robert, Lluis M. Mir, Colum. Dunne et Claire Cronin; deuxième rangée, Declan Sedon, Jean-Rémi.

Netzwerk-Profile

(1 - 4 von 20

–alle anzeigen

)

Facebook: Nassim Morsli | Facebook

LinkedIn: Nassim Morsli | LinkedIn

Nassim Morslis berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Nassim Morsli dabei hilft ...

LinkedIn: Nassim Morsli - Global Clinical Lead Immuno-Oncology LinkedIn

Großbritannien - ‎Global Clinical Lead Immuno-Oncology - ‎Astra Zeneca LP Us#####Sehen Sie sich das Profil von Nassim Morsli auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Nassim Morsli hat 4 Jobs im Profil angegeben. Sehen ...

Interessen

269 Tumoral and peripheral landscape of Viral

jitc.bmj.com

von TH Tan · — Tze Heng Tan,; Sriram Sridhar,; Helen Angell,; Emma Jones,; Amelia Raymond,; Sophie Willis,; Dimitris Polychronopoulos,; Alejandro Yovine,; Nassim Morsli, ... › Suppl_3

Business-Profile

Xing: Nassim Morsli

Médecin chef de projet / Paris

Nassim MORSLI - Dirigeant de la société Milan - Verif.com

www.verif.com

Retrouvez la biographie, l'interview, les coordonnées, les mandats ainsi que toutes les informations concernant Nassim MORSLI sur Verif.com

Private Homepages

Nintedanib Plus Pemetrexed/Cisplatin in Patients With ...ikm.ku.dk › thoracic-surgery › ex...

ikm.ku.dk

... {Mark A} and {von Wangenheim}, Ute and Loemb{\'e}, {Ars{\`e}ne Bienvenu} and Jos{\'e} Barrueco and Nassim Morsli and Giorgio Scagliotti",. year = "2017",.

Bücher

(1 - 4 von 7

–alle anzeigen

)

P2.01: LUME-MeSO: Phase II/III Study of Nintedanib +...

ur.booksc.org

P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma | Scagliotti, Giorgio V.; Gaafar,...

Modern Thoracic Oncology (In 3 Volumes) - Google Books

books.google.ee

Modern Thoracic Oncology is the first comprehensive publication on thoracic oncology. Contributors who are world experts have authored concise, relevant and...

Journal of the National Cancer Institute: JNCI. - Google Books

books.google.de

... Nassim Morsli and Tomohide Tamura The first evaluation of L-BLP25 in Japanese patients with unresectable Stage III non-small-cell lung cancer after primary ...

New Approaches for the Treatment of Muscle Injuries - Tamsin Wright...

books.google.ee

You saved me from making time consuming mistakes. I am so grateful for everything I learned from you. Franck André and Nassim Morsli for being very helpful in ...

Dokumente zum Namen

(1 - 4 von 8

–alle anzeigen

)

7th LATIN AMERICAN CONFERENCE ON LUNG CANCER ABSTRACT BOOK BECOME A...

docplayer.net

... Anna Nowak 3, Nicholas J. Vogelzang 4, Ute Von Wangenheim 5, Nassim Morsli 6, Derek Velema 7, Sanjay Popat 8 1 Department of Oncology, University of ...

LUME-Meso: Design and Rationale of the Phase III Part of a

repository.icr.ac.uk

von GV Scagliotti · · Zitiert von: 17 — Velema,j Nassim Morsli,k Sanjay Popatl. aUniversity of Turin, Department of Oncology, S Luigi Hospital, › handle › internal

Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese ...

academic.oup.com

von F Ohyanagi · · Zitiert von: 49 — Nassim Morsli,. Nassim Morsli. 5. Merck KGaA. ,. Darmstadt. ,. Germany. Search for other works by this author on: Oxford Academic. › jjco › a...

Standard operating procedures of the electrochemotherapy - cliniporator

www.cliniporator.com

... Dr. Marko Snoj, Dr. John Larkin, Pr. Damijan Miklavcic,. Ivan Pavlovic, Dr. Snezna M. Paulin-Kosir, Dr. Maja Cemazar,. Dr. Nassim Morsli, Dr. Declan Soden.

Wissenschaftliche Veröffentlichungen

Successful repetitive treatments by electrochemotherapy of multiple...

www.sciencedirect.com

Jean-Rémi Garbay, Valérie Billard, Claire Bernat, Lluis M. Mir, Nassim Morsli, Caroline Robert. EJC Supplements. Volume 4, Issue 11, Pages (November ...

Veröffentlichungen allgemein

An open-label feasibility study of nintedanib combined with ...

link.springer.com

von N Yamamoto · · Zitiert von: 1 — Nassim Morsli was an employee of Boehringer Ingelheim and is now an employee of AstraZeneca. Isao Saito, Akiko Sarashina and Tetsuya Tanaka ... › article